BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
1/11/2022 12:11:22 AM | Browse: 471 | Download: 979
 |
Received |
|
2021-02-22 13:20 |
|
Peer-Review Started |
|
2021-02-22 13:25 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2021-08-19 18:55 |
|
Revised |
|
2021-09-08 16:50 |
|
Second Decision |
|
2021-12-13 03:32 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2021-12-23 06:28 |
|
Articles in Press |
|
2021-12-23 06:28 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
2021-12-09 02:16 |
|
Typeset the Manuscript |
|
2021-12-31 04:11 |
|
Publish the Manuscript Online |
|
2022-01-11 00:11 |
| ISSN |
1948-5204 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Oncology |
| Manuscript Type |
Review |
| Article Title |
Biomarkers for response to immune checkpoint inhibitors in gastrointestinal cancers
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Meng Li, Denis Kaili and Lei Shi |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| Fundamental Research Funds for the Central Universities |
2019CDYGYB024 |
|
| Corresponding Author |
Lei Shi, PhD, Associate Professor, School of Life Sciences, Chongqing University, No. 174 Shazheng Street, Shapingba District, Chongqing 400044, China. shil@cqu.edu.cn |
| Key Words |
Immunotherapy; Immune Checkpoint Inhibitor; Biomarker; Predictive response; Gastrointestinal cancer |
| Core Tip |
Cancer immunotherapy and immune checkpoint inhibitors (ICIs) have recently revolutionized gastrointestinal (GI) cancer treatment, providing unprecedented clinical benefits. However, GI patients treated with ICIs do not fully benefit, and therefore the identification and development of biomarkers for predicting ICIs response have become a pressing issue to be solved now. In this review, we summarize the use of predictive biomarkers for ICI-treatment in GI cancers, and discussed novel biomarkers under development. We also presented important biomarkers in other tumors with the aim of providing a cutting-edge reference for GI cancers research. |
| Publish Date |
2022-01-11 00:11 |
| Citation |
Li M, Kaili D, Shi L. Biomarkers for response to immune checkpoint inhibitors in gastrointestinal cancers. World J Gastrointest Oncol 2022; 14(1): 19-37 |
| URL |
https://www.wjgnet.com/1948-5204/full/v14/i1/19.htm |
| DOI |
https://dx.doi.org/10.4251/wjgo.v14.i1.19 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
